Cellcept and Daptomycin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cellcept (mycophenolate mofetil) and Daptomycin (daptomycin). Common drug interactions include agranulocytosis among females and antisynthetase syndrome among males.

The phase IV clinical study analyzes what interactions people have when they take Cellcept and Daptomycin. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.

What is Daptomycin?

Daptomycin has active ingredients of daptomycin. eHealthMe is studying from 7,879 Daptomycin users. Check the latest studies of Daptomycin.

On Jul, 10, 2026

26 people who take Cellcept and Daptomycin together, and have interactions are studied.

Cellcept and Daptomycin drug interactions.

What are the common drug interactions of Cellcept and Daptomycin, by gender? *:

female:

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Leukopenia (less number of white blood cells in blood)
Neutropenia (an abnormally low number of neutrophils)
Acute respiratory failure
Fungaemia (fungi circulate in the blood)
Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
Asthenia (weakness)
Bacteraemia (presence of bacteria in the blood)
Colitis (inflammation of colon)
Decreased appetite

male:

Antisynthetase syndrome (chronic autoimmune disease of unknown cause)
Fatigue (feeling of tiredness)
Pulmonary hypertension (increase in blood pressure in the lung artery)
Rash
Tenderness (pain or discomfort when an affected area is touched)
White blood cell count increased
Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
Bile duct stenosis (abnormal narrowing of the common bile duct)
Cholangitis sclerosing (infection and obstruction of bile duct)
Enterococcal infection

What are the common drug interactions of Cellcept and Daptomycin, by age (0-1 to 60+)? *:

0-1:

Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)

2-9:

n/a

10-19:

n/a

20-29:

Hepatobiliary disease (diseases affect the liver and/or biliary tract)

30-39:

Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
Acute respiratory distress syndrome
Ammonia increased
Cardiac arrest
Enterococcal bacteraemia (presence of bacteria lactic acid in the blood)
Escherichia urinary tract infection (urinary tract infection by escherichia coli)
Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Respiratory failure (inadequate gas exchange by the respiratory system)
Sepsis (a severe blood infection that can lead to organ failure and death)

40-49:

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Leukopenia (less number of white blood cells in blood)
Neutropenia (an abnormally low number of neutrophils)
Complications of transplanted lung

50-59:

Asthenia (weakness)
Bile duct stenosis (abnormal narrowing of the common bile duct)
Cholangitis sclerosing (infection and obstruction of bile duct)
Decreased appetite
Enterococcal infection
General physical health deterioration (weak health status)
Platelet count decreased
Respiratory failure (inadequate gas exchange by the respiratory system)
Septic shock (shock due to blood infection)
Vomiting

60+:

Acute respiratory failure
Fungaemia (fungi circulate in the blood)
Osteomyelitis (infection of bone)
Peripheral swelling
Pleuritic pain
Pruritus (severe itching of the skin)
Pulmonary hypertension (increase in blood pressure in the lung artery)
Rash
Tenderness (pain or discomfort when an affected area is touched)
White blood cell count increased

What are the existing conditions these people have? *

Fungal Infection: 4 people, 15.38%
Diarrhea: 3 people, 11.54%
Nausea (feeling of having an urge to vomit): 3 people, 11.54%
White Blood Cell Disorder: 2 people, 7.69%
Hypersensitivity: 2 people, 7.69%
Dehydration (dryness resulting from the removal of water): 2 people, 7.69%
Febrile Neutropenia (fever with reduced white blood cells): 2 people, 7.69%
Fever: 2 people, 7.69%
Fluid Overload (too much fluid in the blood): 2 people, 7.69%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Cellcept and Daptomycin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously